Cargando…
A Novel Non-Invasive Approach Based on Serum Ceruloplasmin for Identifying Non-Alcoholic Steatohepatitis Patients in the Non-Diabetic Population
BACKGROUND AND AIM: Few non-invasive models were established to identify patients with non-alcoholic steatohepatitis (NASH). Liver biopsy remains the gold standard in the clinic. Decreased serum ceruloplasmin (CP) is reported in patients with non-alcoholic fatty liver disease (NAFLD). We aimed to de...
Autores principales: | Wang, Qingling, Zhou, Da, Wang, Mingjie, Zhu, Mingyu, Chen, Peizhan, Li, Hu, Lu, Meng, Zhang, Xinxin, Shen, Xizhong, Liu, Taotao, Chen, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9252518/ https://www.ncbi.nlm.nih.gov/pubmed/35795637 http://dx.doi.org/10.3389/fmed.2022.900794 |
Ejemplares similares
-
Assessing whether serum ceruloplasmin promotes non-alcoholic steatohepatitis via regulating iron metabolism
por: Xia, Ziqiang, et al.
Publicado: (2023) -
Combined Serum Biomarkers in Non-Invasive Diagnosis of Non-Alcoholic Steatohepatitis
por: Yang, Mei, et al.
Publicado: (2015) -
Non-alcoholic Steatohepatitis Pathogenesis, Diagnosis, and Treatment
por: Zhu, Bo, et al.
Publicado: (2021) -
Statins in Non-alcoholic Steatohepatitis
por: Torres-Peña, Jose D., et al.
Publicado: (2021) -
Ursodeoxycholic Acid Treatment Restores Gut Microbiota and Alleviates Liver Inflammation in Non-Alcoholic Steatohepatitic Mouse Model
por: Li, Hu, et al.
Publicado: (2021)